Simultaneous Determination of Dapagliflozin and Bisoprolol by LC–MS/MS: Method Development, Validation, and Forced Degradation Studies

In the complex world of modern medicine, doctors often prescribe combinations of drugs to manage conditions that affect multiple systems in the body. For patients living with type 2 diabetes who also face high blood pressure or heart risks, a specific pairing of medications has become a vital tool. One drug helps the kidneys filter out excess sugar from the blood, while the other works to relax the heart and lower blood pressure. When these two medicines are combined into a single pill, they offer a streamlined way to treat both conditions at once. However, before such a pill can be trusted by millions of people, scientists must prove that the ingredients remain stable and effective over time. They need to know exactly how much of each drug is present and ensure that the manufacturing process or storage conditions have not caused the medicines to break down into something less useful or potentially harmful.

To guarantee this safety and quality, researchers rely on a technique that acts like a highly sensitive molecular scale. This method, known as liquid chromatography-tandem mass spectrometry, separates a mixture of chemicals into its individual components and then identifies them by their weight and electrical charge. It is a powerful way to look at a complex substance and see exactly what is inside, down to the tiniest trace amounts. For a long time, scientists had to use different, less precise tools to check these two specific drugs separately, or they had to rely on methods that could not clearly distinguish the drugs from their broken-down pieces. This gap in knowledge meant that quality control for the combined pill was not as thorough as it could be.

A team of researchers at M. S. Ramaiah University of Applied Sciences in India set out to fix this by creating a single, highly precise method to measure both dapagliflozin and bisoprolol at the same time. Their goal was to build a testing protocol that could not only count the amount of each drug in a tablet but also act as a stability indicator. This means the method would be able to spot if the drugs had started to degrade, or break apart, due to exposure to harsh conditions like heat, light, or chemicals. By developing this new approach, they aimed to provide a gold-standard tool for pharmaceutical companies to ensure that every batch of these combination pills meets strict safety and quality requirements.

The researchers began by designing a system that could separate the two drugs as they flowed through a tiny column filled with microscopic beads. They carefully adjusted the liquid mixture that carried the drugs through this column, testing different combinations of water, methanol, and special salts to find the perfect balance. Early attempts showed that the drugs were not separating cleanly or were leaving behind traces that interfered with the next test. Through a process of trial and error, they refined the liquid mixture and reduced the amount of sample injected into the machine. This adjustment allowed them to get sharp, clear signals for both drugs without any confusion or leftover residue from previous tests. The final setup used a column that was about the length of a standard pen, packed with beads so small they could be measured in micrometers, allowing for a very fast and efficient separation.

Once the separation was perfected, the team turned their attention to the detection system, which acts as the eyes of the machine. They programmed the instrument to look for specific signatures of the two drugs as they exited the column. To ensure the results were accurate, they included two other similar drugs as reference points, which helped the machine correct for any tiny fluctuations in the process. The researchers then tested their new method against a rigorous set of rules established by international health authorities. They checked if the machine could consistently detect the drugs at very low levels, if the results were the same when the test was repeated multiple times, and if the method could accurately measure the drugs even when the conditions were slightly changed, such as a small shift in temperature or flow speed.

The results showed that the new method was highly reliable. It could detect the drugs at levels as low as a few hundred nanograms per milliliter, which is an incredibly small amount, and it could measure them accurately across a wide range of concentrations. When the researchers tested the precision of the method, the results were consistent every time, with very little variation between different tests. They also checked the accuracy by adding known amounts of the drugs to the samples and seeing if the machine could find exactly what was added. The method found the correct amounts with a high degree of certainty, proving that it could be trusted for routine quality control.

A critical part of the study involved testing how the drugs behaved under stress, simulating the harsh conditions they might face during manufacturing or storage. The researchers exposed the drugs to acidic and basic solutions, strong oxidizing agents, high heat, and bright light. They wanted to see if the drugs would break down under these conditions and if their new method could spot the broken pieces. The study found that both dapagliflozin and bisoprolol were remarkably stable. Even after being subjected to these stressful environments, the vast majority of the drugs remained intact, with recovery rates staying above ninety-eight percent. Crucially, the method did not detect any significant new peaks that would indicate the formation of harmful breakdown products. This confirmed that the drugs are robust and that the new testing method is sensitive enough to catch any potential issues, even if they were to occur.

The researchers also tested the method on actual tablets available in the market, not just pure chemical powders. They crushed the tablets, dissolved the contents, and ran them through the system. The method worked just as well on the finished product as it did on the pure ingredients, successfully measuring the amount of each drug and confirming that the tablet formulation did not interfere with the results. This is a vital step, as it proves the method can be used in real-world scenarios to check the quality of medicine that patients will actually take. The study concluded that this new technique is a robust, sensitive, and reliable tool for ensuring the quality of these combination pills. By providing a clear and accurate way to measure both drugs simultaneously and check their stability, the researchers have offered a valuable resource for maintaining the safety and efficacy of a treatment that helps millions of people manage their health.